PCM
WVE icon

Pinz Capital Management’s Wave Life Sciences WVE Stock Holding History

Pinz Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-574,273
Closed -$4.88M – 197
2020
Q3 		$4.88M Buy
+574,273
New +$6.29M 1.78% 18

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pinz Capital Management's WVE Position: Q4 2020 in Review

Pinz Capital Management sold out of Wave Life Sciences (WVE) in Q4 2020, closing a stake of 574,273 shares — an estimated $4.88M sold.

Pinz Capital Management first reported a position in WVE in Q3 2020 and held it in 1 quarter. The position peaked at $4.88M in Q3 2020. 108 funds tracked by Wall St. Rank hold WVE as of Q4 2020.

  • Pinz Capital Management reported no remaining Wave Life Sciences position as of Q4 2020 after selling out during the quarter.
  • Pinz Capital Management sold 574,273 Wave Life Sciences shares in Q4 2020, an estimated $4.88M.
  • Pinz Capital Management first reported a position in Wave Life Sciences in Q3 2020 and held it in 1 quarter.
  • Pinz Capital Management's Wave Life Sciences position peaked at $4.88M in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2020.

Based on Pinz Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.